- Loading stock data...
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.
Dexcom projects 37.8% earnings growth for the next five years. Over the past year, the company’s share price has risen 152.2% compared with the industry’s 16.1% growth.
If you found this site useful and want to help keep it alive,
to cover the costs and keep the site free of advertisements! Thank you for your support!